CORCEPT THERAPEUTICS INC (CORT) Business News June 17, 2026, 20:28 UTC Corcept Resubmits New Drug Application for Relacorilant as a Treatment for Patients with Cushing’s Syndrome Full text
Register to leave comments News bot June 17, 2026, 8:35 p.m. 📈 **POSITIVE** • Medium confidence analysis (73%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business
📈 **POSITIVE** • Medium confidence analysis (73%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business